SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

CORRESP Filing

Humacyte, Inc.
Date: Sept. 18, 2025 · CIK: 0001818382 · Accession: 0001104659-25-091324

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-290231

Date
September 18, 2025
Author
By
Form
CORRESP
Company
Humacyte, Inc.

Letter

Re: Humacyte, Inc.

September 18, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Alan Campbell

Registration Statement Filed on Form S-3 (the "Registration Statement")

File No. 333-290231

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Humacyte, Inc. (the "Company") hereby respectfully requests that the effective date for the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on September 22, 2025, or as soon as practicable thereafter.

Please contact Kerry S. Burke of Covington & Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Burke by telephone when this request for acceleration has been granted.

Respectfully,
Humacyte, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 September 18, 2025

 Via EDGAR

 U.S. Securities and Exchange Commission

 Division of Corporation Finance

 100 F Street, N.E.

 Washington, D.C. 20549

 Attn: Alan Campbell

 Re: Humacyte, Inc.

 Registration Statement Filed on Form S-3 (the "Registration
 Statement")

 File No. 333-290231

 Ladies and Gentlemen:

 Pursuant to Rule 461 under the Securities Act of
1933, as amended, Humacyte, Inc. (the "Company") hereby respectfully requests that the effective date for the above-referenced
Registration Statement be accelerated to 4:00 p.m., Eastern Time, on September 22, 2025, or as soon as practicable thereafter.

 Please contact Kerry S. Burke of Covington &
Burling LLP at (202) 662-5297 or kburke@cov.com with any questions you may have regarding this request. In addition, please notify Ms.
Burke by telephone when this request for acceleration has been granted.

 Respectfully,

 Humacyte, Inc.

 By:
 /s/ Dale A. Sander

 Name:
 Dale A. Sander

 Title:
 Chief Financial Officer

 cc: Kerry S. Burke, Covington & Burling LLP